Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Dietary vitamin C, E, and carotenoid intake and risk of renal cell carcinoma
Cancer Causes and Control, 06/24/09
Hu J et al. - In a trial to examine the association between dietary intake of vitamin C, E, and carotenoids and risk of renal cell carcinoma (RCC), the findings provide evidence that a diet rich in β-carotene and lutein/zeaxanthin may play a role in RCC prevention.
Methods- Mailed questionnaires were completed by 1138 incident, histologically confirmed cases of RCC and 5039 population controls, including information on socio-economic status, lifestyle habits, and diet.
- A 69-item food frequency questionnaire provided data on eating habits 2 yrs before data collection.
- Odds ratios (OR) and 95% confidence intervals (CI) were computed using unconditional logistic regression.
- Dietary intake of β-carotene and lutein/zeaxanthin was inversely associated with risk of RCC.
- ORs for the highest vs the lowest quartile were 0.74 and 0.77, respectively.
- The significant inverse association with β-carotene and lutein/zeaxanthin was more pronounced in women, and in overweight or obese subjects.
- The relation of lutein/zeaxanthin to RCC was stronger in ever smokers.
- No clear association was observed with vitamin C and E, β-cryptozanthin, and lycopene.
Jinfu Hu, 06/29/09
| The large population based case-control study uses of a widely used and validated food frequency questionnaire to evaluate several dietary factors in relation to renal cell carcinoma. Findings suggested a significant inverse association between dietary intake of ?-carotene and lutein/zeaxanthin and renal cell carcinoma. Further discussion is included in the article. |
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pseudopheochromocytoma: An uncommon cause of malignant hypertension
Indian Journal of Nephrology, 10/16/09
Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09
New treatment approaches in renal cell carcinoma
Anti-Cancer Drugs, 10/15/09
Article Search
Sponsor


See Latest Articles


